IBDEI0KF ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25854,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25854,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25854,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25855,0)
 ;;=F02.81^^69^1063^44
 ;;^UTILITY(U,$J,358.3,25855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25855,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25855,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25855,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25856,0)
 ;;=F02.80^^69^1063^45
 ;;^UTILITY(U,$J,358.3,25856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25856,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25856,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25856,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25857,0)
 ;;=G31.84^^69^1063^62
 ;;^UTILITY(U,$J,358.3,25857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25857,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,25857,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,25857,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,25858,0)
 ;;=A81.9^^69^1063^71
 ;;^UTILITY(U,$J,358.3,25858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25858,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,25858,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,25858,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,25859,0)
 ;;=F02.81^^69^1063^32
 ;;^UTILITY(U,$J,358.3,25859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25859,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25859,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25859,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25860,0)
 ;;=F02.80^^69^1063^33
 ;;^UTILITY(U,$J,358.3,25860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25860,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25860,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25860,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25861,0)
 ;;=G31.84^^69^1063^63
 ;;^UTILITY(U,$J,358.3,25861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25861,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,25861,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,25861,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,25862,0)
 ;;=S06.2X9S^^69^1063^74
 ;;^UTILITY(U,$J,358.3,25862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25862,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,25862,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,25862,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,25863,0)
 ;;=F02.81^^69^1063^50
 ;;^UTILITY(U,$J,358.3,25863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25863,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25863,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25863,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25864,0)
 ;;=F02.80^^69^1063^51
 ;;^UTILITY(U,$J,358.3,25864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25864,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25864,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25864,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25865,0)
 ;;=G31.84^^69^1063^64
 ;;^UTILITY(U,$J,358.3,25865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25865,1,3,0)
 ;;=3^Mild Neurocog D/O d/t TBI
 ;;^UTILITY(U,$J,358.3,25865,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,25865,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,25866,0)
 ;;=F01.51^^69^1063^48
 ;;^UTILITY(U,$J,358.3,25866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25866,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25866,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,25866,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,25867,0)
 ;;=F01.50^^69^1063^49
 ;;^UTILITY(U,$J,358.3,25867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25867,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25867,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,25867,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,25868,0)
 ;;=G31.84^^69^1063^65
 ;;^UTILITY(U,$J,358.3,25868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25868,1,3,0)
 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
 ;;^UTILITY(U,$J,358.3,25868,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,25868,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,25869,0)
 ;;=R41.9^^69^1063^68
 ;;^UTILITY(U,$J,358.3,25869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25869,1,3,0)
 ;;=3^Neurocognitive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25869,1,4,0)
 ;;=4^R41.9
 ;;^UTILITY(U,$J,358.3,25869,2)
 ;;=^5019449
 ;;^UTILITY(U,$J,358.3,25870,0)
 ;;=F06.31^^69^1064^1
 ;;^UTILITY(U,$J,358.3,25870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25870,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
 ;;^UTILITY(U,$J,358.3,25870,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,25870,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,25871,0)
 ;;=F06.32^^69^1064^2
 ;;^UTILITY(U,$J,358.3,25871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25871,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
 ;;^UTILITY(U,$J,358.3,25871,1,4,0)
 ;;=4^F06.32
 ;;^UTILITY(U,$J,358.3,25871,2)
 ;;=^5003058
 ;;^UTILITY(U,$J,358.3,25872,0)
 ;;=F32.9^^69^1064^20
 ;;^UTILITY(U,$J,358.3,25872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25872,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,25872,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,25872,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,25873,0)
 ;;=F32.0^^69^1064^17
 ;;^UTILITY(U,$J,358.3,25873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25873,1,3,0)
 ;;=3^MDD,Single Episode,Mild
 ;;^UTILITY(U,$J,358.3,25873,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,25873,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,25874,0)
 ;;=F32.1^^69^1064^18
 ;;^UTILITY(U,$J,358.3,25874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25874,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,25874,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,25874,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,25875,0)
 ;;=F32.2^^69^1064^19
 ;;^UTILITY(U,$J,358.3,25875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25875,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,25875,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,25875,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,25876,0)
 ;;=F32.3^^69^1064^14
 ;;^UTILITY(U,$J,358.3,25876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25876,1,3,0)
 ;;=3^MDD,Single Episode w Psychotic Features
 ;;^UTILITY(U,$J,358.3,25876,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,25876,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,25877,0)
 ;;=F32.4^^69^1064^16
 ;;^UTILITY(U,$J,358.3,25877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25877,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,25877,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,25877,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,25878,0)
 ;;=F32.5^^69^1064^15
 ;;^UTILITY(U,$J,358.3,25878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25878,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,25878,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,25878,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,25879,0)
 ;;=F33.9^^69^1064^13
 ;;^UTILITY(U,$J,358.3,25879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25879,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,25879,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,25879,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,25880,0)
 ;;=F33.0^^69^1064^10
 ;;^UTILITY(U,$J,358.3,25880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25880,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,25880,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,25880,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,25881,0)
 ;;=F33.1^^69^1064^11
 ;;^UTILITY(U,$J,358.3,25881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25881,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,25881,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,25881,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,25882,0)
 ;;=F33.2^^69^1064^12
 ;;^UTILITY(U,$J,358.3,25882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25882,1,3,0)
 ;;=3^MDD,Recurrent Episode,Severe
 ;;^UTILITY(U,$J,358.3,25882,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,25882,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,25883,0)
 ;;=F33.3^^69^1064^7
 ;;^UTILITY(U,$J,358.3,25883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25883,1,3,0)
 ;;=3^MDD,Recurrent Episode w/ Psychotic Features
 ;;^UTILITY(U,$J,358.3,25883,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,25883,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,25884,0)
 ;;=F33.41^^69^1064^9
 ;;^UTILITY(U,$J,358.3,25884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25884,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,25884,1,4,0)
 ;;=4^F33.41
 ;;^UTILITY(U,$J,358.3,25884,2)
 ;;=^5003534
 ;;^UTILITY(U,$J,358.3,25885,0)
 ;;=F33.42^^69^1064^8
 ;;^UTILITY(U,$J,358.3,25885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25885,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,25885,1,4,0)
 ;;=4^F33.42
 ;;^UTILITY(U,$J,358.3,25885,2)
 ;;=^5003535
 ;;^UTILITY(U,$J,358.3,25886,0)
 ;;=F34.8^^69^1064^6
 ;;^UTILITY(U,$J,358.3,25886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25886,1,3,0)
 ;;=3^Disruptive Mood Dysregulation Disorder
 ;;^UTILITY(U,$J,358.3,25886,1,4,0)
 ;;=4^F34.8
 ;;^UTILITY(U,$J,358.3,25886,2)
 ;;=^5003539
 ;;^UTILITY(U,$J,358.3,25887,0)
 ;;=F34.1^^69^1064^21
 ;;^UTILITY(U,$J,358.3,25887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25887,1,3,0)
 ;;=3^Persistent Depressive Disorder (Dysthmia)
 ;;^UTILITY(U,$J,358.3,25887,1,4,0)
 ;;=4^F34.1
 ;;^UTILITY(U,$J,358.3,25887,2)
 ;;=^331913
 ;;^UTILITY(U,$J,358.3,25888,0)
 ;;=N94.3^^69^1064^22
 ;;^UTILITY(U,$J,358.3,25888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25888,1,3,0)
 ;;=3^Premenstrual Dysphoric Disorder
